Literature DB >> 2442992

Diuretics, serum potassium and ventricular arrhythmias in the Multiple Risk Factor Intervention Trial.

J D Cohen, J D Neaton, R J Prineas, K A Daniels.   

Abstract

To examine the relation between diuretic use and ventricular premature complexes (VPCs) in the Multiple Risk Factor Intervention Trial, data derived from the baseline and annual rest electrocardiograms were analyzed for men in the special-intervention (SI) and usual-care (UC) groups. At baseline, age, diuretic use and presence of other rest electrocardiographic abnormalities were significantly associated with the prevalence of VPCs. Among diuretic users at baseline, those with lower serum potassium levels were most likely to have VPCs. Over the follow-up period among nonhypertensive persons the relative risk (SI/UC) for the occurrence of VPCs during follow-up was 0.83, and for hypertensives this relative risk increased linearly from 1.08 to 1.42, with higher levels of diastolic blood pressure at entry (p less than 0.01 for linear trend of relative risk estimates). This was due to an increasing risk among the SI group, and the risk was independent of the presence or absence of rest electrocardiographic abnormalities at baseline. The relative risk estimate, diuretic vs no diuretic, for development of VPCs was approximately 1.2 (p = 0.04) for SI men and 1.1 (p = 0.35) for UC men. The reduction in serum potassium level was greater for those with VPCs, and regression analysis showed that low serum potassium levels were significantly associated with the incidence of VPCs in both study groups. These data confirm and quantify the relation between diuretic drugs and VPCs and suggest that at least 1 mechanism of diuretic-induced VPCs is potassium depletion.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2442992     DOI: 10.1016/0002-9149(87)90303-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  21 in total

Review 1.  Fortnightly review: Beneficial effects of potassium.

Authors:  F J He; G A MacGregor
Journal:  BMJ       Date:  2001-09-01

2.  Outcomes after the long interdialytic break: implications for the dialytic prescription.

Authors:  Jennifer E Flythe; Eduardo Lacson
Journal:  Semin Dial       Date:  2012 Jan-Feb       Impact factor: 3.455

3.  Thiazide diuretic prescription and electrolyte abnormalities in primary care.

Authors:  J A Clayton; S Rodgers; J Blakey; A Avery; I P Hall
Journal:  Br J Clin Pharmacol       Date:  2006-01       Impact factor: 4.335

4.  Clinical predictors of treatment reduction in hypertensive patients.

Authors:  J F Steiner; S D Fihn; T D Koepsell; B Blair; K Kelleher; D D'Alessandro; T S Inui
Journal:  J Gen Intern Med       Date:  1990 May-Jun       Impact factor: 5.128

5.  Differential conditions for early after-depolarizations and triggered activity in cardiomyocytes derived from transgenic LQT1 and LQT2 rabbits.

Authors:  Gong-Xin Liu; Bum-Rak Choi; Ohad Ziv; Weiyan Li; Enno de Lange; Zhilin Qu; Gideon Koren
Journal:  J Physiol       Date:  2011-12-19       Impact factor: 5.182

6.  Spontaneous initiation of premature ventricular complexes and arrhythmias in type 2 long QT syndrome.

Authors:  Xiaodong Huang; Tae Yun Kim; Gideon Koren; Bum-Rak Choi; Zhilin Qu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-10-07       Impact factor: 4.733

7.  Serum potassium and cardiovascular mortality.

Authors:  J Fang; S Madhavan; H Cohen; M H Alderman
Journal:  J Gen Intern Med       Date:  2000-12       Impact factor: 5.128

Review 8.  Adverse metabolic effects of antihypertensive drugs. Implications for treatment.

Authors:  H G Preuss; J F Burris
Journal:  Drug Saf       Date:  1996-06       Impact factor: 5.606

Review 9.  Goals of antihypertensive therapy.

Authors:  G E McVeigh; J Flack; R Grimm
Journal:  Drugs       Date:  1995-02       Impact factor: 9.546

10.  Prevention of atherosclerotic complications: controlled trial of ketanserin. Prevention of Atherosclerotic Complications with Ketanserin Trial Group.

Authors: 
Journal:  BMJ       Date:  1989-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.